Department of General Surgery, Third Xiangya Hospital, Central South University, Changsha, 410013, China.
Surg Today. 2022 Feb;52(2):287-293. doi: 10.1007/s00595-021-02317-2. Epub 2021 Jun 9.
To evaluate the long-term efficacy of large gastric pouch surgery and revisional surgery in patients with a body mass index (BMI) < 35 kg/m and type 2 diabetes mellitus (T2DM).
We conducted a retrospective review of patients who underwent laparoscopic Roux-en-Y gastrojejunostomy with a large gastric pouch in our hospital. The clinical pre- and post-surgery data, including BMI, waist circumference, fasting plasma glucose (FPG), glycated hemoglobin (HbA1c), lipid metabolism-related indicators, homoeostatic model assessment of insulin resistance (HOMA-IR), and major complications, were recorded and analyzed.
Twenty-four patients were included in the analysis, 12 of whom underwent revisional surgery. At their 5-year-follow-up after the primary surgery, the BMI and waist circumference of the patients with T2DM were lower than their baseline values. The BMI, HbA1c, HOMA-IR, FPG and waist circumference also decreased after the revisional surgery. The rates of remission of diabetes after the primary vs. after the revisional surgery were 4.17% vs. 41.70%, respectively (P < 0.05).
Roux-en-Y gastrojejunostomy with a large gastric pouch is not effective in the long term and, therefore, is unsuitable for Chinese patients with T2DM and a BMI < 35 kg/m. Conversely, revisional surgery has a definite effect on these patients.
评估胃旁路术联合大胃囊术治疗体重指数(BMI)<35kg/m2 合并 2 型糖尿病(T2DM)患者的长期疗效及翻修手术的疗效。
回顾性分析我院行腹腔镜下 Roux-en-Y 胃旁路术联合大胃囊术的患者临床资料,记录并分析患者术前及术后 BMI、腰围、空腹血糖(FPG)、糖化血红蛋白(HbA1c)、脂代谢相关指标、稳态模型评估的胰岛素抵抗指数(HOMA-IR)及主要并发症等临床指标。
共纳入 24 例患者,其中 12 例行翻修手术。初次手术后 5 年随访时,患者 BMI 和腰围较术前均降低,且翻修术后 BMI、HbA1c、HOMA-IR、FPG 及腰围较术前进一步降低。初次手术与翻修手术后糖尿病缓解率分别为 4.17%和 41.70%(P<0.05)。
胃旁路术联合大胃囊术长期疗效不佳,不适合中国 BMI<35kg/m2 合并 T2DM 的患者。翻修手术对此类患者有明确疗效。